- Previous Close
4.4300 - Open
4.4200 - Bid 4.3500 x 800
- Ask 4.3900 x 900
- Day's Range
4.3400 - 4.5250 - 52 Week Range
4.2000 - 13.1300 - Volume
28,988 - Avg. Volume
266,569 - Market Cap (intraday)
126.091M - Beta (5Y Monthly) 0.92
- PE Ratio (TTM)
-- - EPS (TTM)
-1.0400 - Earnings Date May 7, 2025 - May 12, 2025
- Forward Dividend & Yield 0.12 (2.71%)
- Ex-Dividend Date Jun 26, 2024
- 1y Target Est
14.00
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.
www.american-vanguard.com845
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AVD
View MorePerformance Overview: AVD
Trailing total returns as of 3/31/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AVD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AVD
View MoreValuation Measures
Market Cap
127.53M
Enterprise Value
316.58M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.22
Price/Book (mrq)
0.39
Enterprise Value/Revenue
0.57
Enterprise Value/EBITDA
67.24
Financial Highlights
Profitability and Income Statement
Profit Margin
-5.22%
Return on Assets (ttm)
-0.22%
Return on Equity (ttm)
-8.43%
Revenue (ttm)
553.84M
Net Income Avi to Common (ttm)
-28.93M
Diluted EPS (ttm)
-1.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
11.88M
Total Debt/Equity (mrq)
61.27%
Levered Free Cash Flow (ttm)
88.87M